Zoetis Inc.
corporate_fare Company Profile
Zoetis Inc. (NYSE:ZTS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 17 items for ZTS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for ZTS spans 10-Q, 8-K, DEF 14A, 10-K.
Recent high-impact activity:
- Zoetis Beats Q3 Estimates and Raises Guidance, Yet Shares Slide 6% on Pet-Spending Caution
- Zoetis Q3 10-Q: Revenue Down 1%, Net Income Down 18% to $591M
- Zoetis Q3 Revenue Slips 1% as U.S. Pet Sales Fall 8%, but Raises Full-Year Adjusted EPS Outlook
- FDA Grants Emergency Use Authorization for Zoetis' Simparica Trio Against New World Screwworm
- Zoetis Q2 2026: Flat Revenue as U.S. Companion Animal Weakness Meets Restructuring and Legal Headwinds
Financial Snapshot
Short Interest & Short Volume
4.78 days to coverFINRA reported short interest of 16,722,420 shares in ZTS as of the October 30, 2026 settlement, a 4.5% decrease from the prior period — about 4.8 days to cover at its recent average daily volume. On November 20, 2026, 25.9% of ZTS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.